Abstract
This study describes a cohort of working age adults from a novel data linkage. The data linkage is comprised of routine electronic mental health records from The South London and Maudsley (SLaM) NHS Foundation Trust and benefits records from The Department for Work and Pensions (DWP). The data linkage spans 15 years, with SLaM data covering the period 2007-2019 and DWP data covering the period 2005-2020. The linkage was established to investigate the interrelationships between benefit receipt and mental health (including mental health service utilisation) in patients accessing secondary mental health services in South London, UK. Clinical data from SLaM includes information on sociodemographics, diagnoses, assessments, treatments, interventions, and service interaction. Benefits data from DWP provides information on benefit types received, spell dates and entitlement amounts, work capability assessments and work programme access.
This cohort included all working age adults (aged 18-65 years) referred to/receiving treatment from SLaM services between January 2007 and June 2019. We report the sociodemographics and psychiatric diagnoses of n=150,348 working age adults, as well as the types of benefits received. We showed that 78.3% of working age adults received a benefit relating to unemployment or work-related income, sickness or disability, or a housing benefit, and that 68.0% of this group had a recorded primary psychiatric diagnosis. The most commonly received diagnoses were alcohol related disorders and substance related disorders (17.2%), followed by mood (affective) disorders (16.5%). We also observed that nearly 70% of claimants who had received more than one benefit were residing in the two most deprived areas across the South London boroughs covered by SLaM.
Competing Interest Statement
Matthew Hotopf is principal investigator of the RADAR-CNS consortium, a public private pre-competitive consortium on mobile health, and as such received research funding to his university from five pharmaceutical companies (Janssen, UCB, MSD, Lundbeck and Biogen).
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The South London and Maudsley (SLaM) NHS Foundation Trust and Department for Work and Pensions (DWP) data linkage resulted in a linked data set of longitudinal data from SLaM electronic mental health records and DWP benefits data. All data used is de-identified. The use of SLaM mental health records data for research purposes received full ethical approval from the NHS Research Ethics Committee (Oxford South Central ref 18/SC/0372). Ethical approval for the data linkage was granted from the Oxford South Central REC (Ref: 22/SC/0400), and the data linkage was legally permitted by the Health Research Authority Confidentiality Group (CAG) under Section 251 of the NHS Act 2006 (ref 17/CAG/0055).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.